News

Published on 20 Aug 2024 on GuruFocus.com · via Yahoo Finance

Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating &...

Article preview image

On August 20, 2024, Steve Miller, the Chief Operating & Scientific Officer of Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), sold 150,000 shares of the company. The transaction was documented in a recent SEC Filing. Following this sale, the insider now owns 675,124 shares of the company.

Warning! GuruFocus has detected 6 Warning Sign with CPRX.

Read the rest of the article
NASDAQ.CPRX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock's On An Uptrend: Are Strong...

Catalyst Pharmaceuticals (NASDAQ:CPRX) has had a great run on the share market with its stock up ...

Simply Wall St. · via Yahoo Finance 4 Dec 2024
Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Call Highlights: Strong...

Catalyst Pharmaceuticals Inc (CPRX) reports a 25.3% increase in total revenue and updates its...

GuruFocus.com · via Yahoo Finance 11 Nov 2024
Catalyst Pharmaceuticals Inc (CPRX) Q3 2024 Earnings Report Preview: What To...

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) is set to release its Q3 2024 earnings on Nov 7, 2024....

GuruFocus.com · via Yahoo Finance 6 Nov 2024
Insider Sale at Catalyst Pharmaceuticals Inc (CPRX): Chief Operating &...

On August 20, 2024, Steve Miller, the Chief Operating & Scientific Officer of Catalyst Pharmaceut...

GuruFocus.com · via Yahoo Finance 20 Aug 2024
Catalyst Pharmaceuticals, Inc.'s (NASDAQ:CPRX) Stock Been Rising: Are Strong...

Most readers would already know that Catalyst Pharmaceuticals' (NASDAQ:CPRX) stock increased by 4...

Simply Wall St. · via Yahoo Finance 19 Jun 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript May 9, 2024 Catalys...

Insider Monkey via Yahoo Finance 10 May 2024
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues

Catalyst Pharmaceuticals, Inc. CPRX reported adjusted earnings of 38 cents per share for the firs...

Zacks via Yahoo Finance 9 May 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) is largely controlled by institutional shareholders who...

Key Insights Given the large stake in the stock by institutions, Catalyst Pharmaceuticals' stock ...

Simply Wall St. via Yahoo Finance 18 Apr 2024
Insider Sell: Chief Compliance/Legal Officer Brian Elsbernd Sells 25,000 Shares of Catalyst ...

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) recently witnessed an insider sell by Chief Compliance...

GuruFocus.com via Yahoo Finance 29 Mar 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2023 Earnings Call Transcript

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q4 2023 Earnings Call Transcript February 29, 2024 C...

Insider Monkey via Yahoo Finance 1 Mar 2024

Copyright Statfolio @ 2024

Social Accounts